Dr Talaulikar is an Associate Specialist in Reproductive Medicine at University College London Hospitals NHS Foundation Trust and Hon. Associate Professor in Women’s Health at the University College London.
He completed his medical studies in India in 2003 followed by a postgraduate degree in obstetrics and gynaecology in 2007.
He is a fellow of the Royal College of Obstetricians and Gynaecologists and completed a PhD degree at St. George’s University of London in 2016.
His clinical interests include reproductive endocrinology, polycystic ovary syndrome, recurrent miscarriage, premature ovarian insufficiency, and menopause.
He is a certified ‘menopause specialist’ by the British Menopause Society and a member of the British Fertility Society, European Society of Human Reproduction and Embryology, British Menopause Society, and International Menopause Society.
He runs a busy menopause and PCOS clinic at UCLH and Menopause Clinic London on Harley Street. He is a Principal trainer for FSRH Menopause SS module and a trainer for BMS principles and practice of menopause care programme
Dr Talaulikar has advanced clinical expertise in the field of reproductive endocrinology, polycystic ovary syndrome, ovulation induction fertility treatment, recurrent miscarriage, premature ovarian insufficiency, and menopause on background of complex medical conditions.
‘’My training and research so far have been primarily in the field of fertility, early pregnancy embryo-uterine interactions and menopause. I envision myself developing a practice in reproductive endocrinology and subfertility focussing on assisted conception, reproductive endocrinology, and post-reproductive health. I also hope to continue conducting research in these areas especially in relation to premature menopause and PCOS. As a teacher and trainer, I hope to be involved in future development of training opportunities and exchange programmes for the benefit of those interested in pursuing a career in subfertility treatment and reproductive endocrinology’’
A list of recent publications:
Cameron-Pimblett A, Davies MC, Burt E, Talaulikar VS, La Rosa C, King TFJ, Conway GS. Effects of Estrogen Therapies on Outcomes in Turner Syndrome: Assessment of Induction of Puberty and Adult Estrogen Use. J Clin Endocrinol Metab. 2019 Jul 1;104(7):2820-26.
Cardona Attard C, Cameron-Pimblett A, Puri D, Elliot J, Wilson JC, Talaulikar VS, Davies MC, Conway GS. Fracture rate in women with oestrogen deficiency – Comparison of Turner syndrome and premature ovarian insufficiency. Clin Endocrinol (Oxf). 2019 Dec;91(6):743-9.
Burt E, Davies MC, Yasmin E, Cameron-Pimblett A, Mavrelos D, Talaulikar V, Conway GS. Reduced uterine volume after induction of puberty in women with hypogonadism. Clin Endocrinol (Oxf). 2019 Dec;91(6):798-804.
Talaulikar VS, Conway GS, Pimblett A, Davies MC. Outcome of ovarian stimulation for oocyte cryopreservation in women with Turner syndrome. Fertil Steril. 2019 Mar;111(3):505-9.
Talaulikar VS, Bajoria R, Ehidiamhen AJ, Mujawar E, Chatterjee R. A 10-year longitudinal study of evaluation of ovarian reserve in women with transfusion-dependent beta thalassaemia major. Eur J Obstet Gynecol Reprod Biol. 2019 Jul;238:38-43.
Mavrelos D, Al Chami A, Talaulikar V, Burt E, Webber L, Ploubidis G, Yasmin E. Variation in antral follicle counts at different times in the menstrual cycle: does it matter? Reproductive BioMedicine Online, 2016; Reproductive Healthcare Ltd. Published by Elsevier Ltd., http://dx.doi.org/10.1016/j.rbmo.2016.04.012.
Wilson A, Brandon R, Cavell D, Murphy E, Stewart F, Thomas S, Talaulikar V and Wilcox G. The experiences and information requirements of women with a mucopolysaccharide (MPS) or related condition during pregnancy, birth and the postnatal period. Abstracts / Molecular Genetics and Metabolism 2016;117:S14–S124.
Talaulikar VS, Khalil A, Bhide A, Garvik TI, Liland F, Lowe V, Ogbomo M, Arulkumaran S. A pilot study of the impact of a novel compression belt on pelvic blood flow in healthy postpartum women, International Journal of Gynecology and Obstetrics (2015).
Talaulikar VS, Hussain S, Perera A, Manyonda IT. Low participation rates amongst Asian women: implications for research in reproductive medicine, European Journal of Obstetrics & Gynecology and Reproductive Biology (2013), http://dx.doi.org/10.1016/j.ejogrb.2013.11.026.
Sinai Talaulikar V, Kronenberger K, Bax BE, Moss R and Manyonda I. Differences in collagen ultrastructure of human first trimester decidua basalis and parietalis: Implications for trophoblastic invasion of the placental bed. J. Obstet. Gynaecol. Res. 2014; 40, 1:80–8.
Gupta S, Talaulikar VS, Onwude J, Manyonda I. A pilot study of Foley’s catheter balloon for prevention of intrauterine adhesions following breach of uterine cavity in complex myoma surgery. Arch Gynecol Obstet. 2013 Apr 12. [Epub ahead of print].
Talaulikar VS, Bax BE, Page NM, Manyonda I. A novel hysteroscopic technique for the accurate biopsy of deciduas parietalis and basalis. Placenta 2012; 33: 473-79.
Ojha K, Gillott DJ, Wood P, Valcarcel E, Matah A, Talaulikar VS. Clinical outcomes from a prospective study evaluating the role of ambulation during medical termination of pregnancy. Contraception 2012; 85(4):398-401.
Talaulikar VS, Chambers T, Manyonda I.Exploiting the antioxidant potential of a common vitamin: Could vitamin C prevent postmenopausal osteoporosis? J Obstet Gynaecol Res 2012; 38(1):253-7.
Reviews
Talaulikar V, Yasmin E. WHO type 1 anovulation: an update on diagnosis,
management and implications for long‐term health. The Obstetrician and
Gynaecologist. First published: 26 March 2020 https://doi.org/10.1111/tog.12665.
Vikram Talaulikar. See your GP about the menopause. The Menopause Exchange,
Issue 82, Page 4, Autumn 2019.
Isaac Manyonda, Vikram S Talaulikar, Roxanna Pirhadi, Joseph Onwude.
Progestogens are the problem in hormone replacement therapy: Time to reappraise
their use. Post Reproductive Health. 2019 Volume: 26 issue: 1, page(s): 26-31.
Vikram Talaulikar, Sabaratnam Arulkumaran. Folic Acid and Reproductive Health.
J Jaffna Sci.Association,2019, 1(1),1-11.
Talaulikar V. HRT Myths in Menopause Exchange Autumn issue, November 2018.
Sauer U, Talaulikar V, Davies MC. Efficacy of intravaginal dehydroepiandrosterone (DHEA) for symptomatic women in the peri- or postmenopausal phase. Maturitas 2018; https://doi.org/10.1016/j.maturitas.2018.07.016.
Devarajan S, Talaulikar VS, Arulkumaran S. Vaginal birth after caesarean, Obstetrics, Gynaecology and Reproductive Medicine (2018), https://doi.org/10.1016/j.ogrm.2018.02.001.
Sinha S, Talaulikar V, Arulkumaran S. Malpositions and malpresentations of the fetal head. Obstetrics, Gynaecology and Reproductive Medicine (2018), https://doi.org/10.1016/j.ogrm.2018.01.001.
Talaulikar V. Continuous combined HRT in Menopause Exchange, Issue 74, Autumn, November 2017.
Viswanatha RK, Sinai Talaulikar V, Sabaratnam A. Intrapartum fetal surveillance. Obstetrics, Gynaecology and Reproductive Medicine (2017), https://doi.org/10.1016/j.ogrm.2017.09.004.
Sinai Talaulikar V. Medical therapy for fibroids: An overview, Best Practice & Research Clinical Obstetrics and Gynaecology (2017), https://doi.org/10.1016/j.bpobgyn.2017.09.007.
Talaulikar V, Saridogan E. Radiological treatments for uterine fibroids. Hospital Healthcare Europe 2017.
Talaulikar V, Saridogan E. Medical treatment of uterine fibroids. Hospital Pharmacy Europe, Issue 85 Spring 2017.
Oliparambil A and Sinai Talaulikar V. Female genital mutilation – the UK perspective. Glob. libr. women’s med., September 2016; GLOWM.
Sinai Talaulikar V, Tang T, Yasmin E. Role of Metformin in Women’s Health: Review of Its Current Place in Clinical Practice and Emerging Indications for Future. Obstetrical and Gynecological Survey 2016;71,5:307-17.
Talaulikar VS, Arulkumaran S. Vaginal birth after caesarean section. Obstetrics, Gynaecology and Reproductive Medicine (2015), http://dx.doi.org/10.1016/j.ogrm.2015.04.005
Talaulikar VS, Arulkumaran S. Malpositions and malpresentations of the fetal head. Obstetrics, Gynaecology and Reproductive Medicine (2015), http://dx.doi.org/10.1016/j.ogrm.2015.03.004
Sinai Talaulikar V. Menopause and hormone replacement therapy. Glob. libr. women’s med., April 2015; GLOWM.
Sinai Talaulikar V, Manyonda I. Mother Initiative Tutorial. Tutorial on Anemia in pregnancy. Glob. libr. women’s med., March 2015; GLOWM.
Sinai Talaulikar V, Manyonda I. Ulipristal acetate for use in moderate to severe symptoms of uterine fibroids. Womens Health (2014) 10(6), 565–570. Future Medicine Ltd.
Sinai Talaulikar V. Anemia in pregnancy. Glob. libr. women’s med., October 2014; GLOWM.
Talaulikar V S. Uterine fibroids and ulipristal. Obstetrics, Gynaecology & Reproductive Medicine. In Press, Corrected Proof, Available online 18 June 2014.
Sinai Talaulikar V, Arulkumaran S. Uterus sparing surgical or radiological treatment of major postpartum haemorrhage: efficacy and implications for future fertility. Glob. libr. women’s med., February 2014; GLOWM.
Talaulikar VS. Ulipristal acetate: a novel medical therapy for uterine fibroids. Glob. libr. women’s med., (ISSN: 1756-2228) 2014; DOI 10.3843/GLOWM.10472.
Talaulikar VS and Arulkumaran S. Hypertensive disorders of pregnancy. Indian Obstetrics and Gynaecology 2013; 1.
Sinai Talaulikar V, Arulkumaran S. Medico-Legal Issues with CTG Interpretation. Current Women’s Health Reviews 2013; 9: 145-57.
Sinai Talaulikar V, Lowe V, Arulkumaran S. Intrapartum fetal surveillance. Case based learning. Obstetrics, Gynaecology and Reproductive Medicine 2014; 24(2):45-55.
Doumouchtsis SK, Nikolopoulos K, Talaulikar VS, Krishna A, Arulkumaran S. Menstrual and fertility outcomes following the surgical management of postpartum haemorrhage: a systematic review. BJOG 2013; DOI: 10.1111/1471-0528.12546.
Talaulikar V, Arulkumaran S. Folic acid in pregnancy. Obstetrics, Gynaecology and Reproductive Medicine 2013; 23(9):286-8.
Talaulikar VS, Arulkumaran S. Maternal, perinatal and long-term outcomes after assisted reproductive techniques (ART): implications for clinical practice. Eur J Obstet Gynecol Reprod Biol. 2013 Aug;170(1):13-9.
Talaulikar VS, Belli A, Manyonda I. GnRH Agonists: Do They Have a Place in the Modern Management of Fibroid Disease? The Journal of Obstetrics and Gynecology of India 2012, 62; 5: 506-10.
Talaulikar VS, Manyonda I. Progesterone and progesterone receptor modulators in the management of symptomatic uterine fibroids. European Journal of Obstetrics & Gynecology and Reproductive Biology 2012; 165(2): 135–40.
Talaulikar VS, Arulkumaran S. Reproductive outcomes after assisted conception. Obstet Gynecol Surv 2012; 67(9):566-83.
Sinai Talaulikar V, Shehata H. Uric acid: is it time to give up routine testing in management of pre-eclampsia? Obstet Med 2012; 5:119-23.
Talaulikar VS, Manyonda IT. Ulipristal acetate: a novel option for the medical management of symptomatic uterine fibroids. Adv Ther 2012; 29(8):655-63.
Talaulikar V, Nagarsekar U. Evidence-Based Medicine: An Obstetrician and Gynaecologist’s Perspective. The Journal of Obstetrics and Gynecology of India 2012; 62(2): 146-53.
Talaulikar V, Arulkumaran S. Malpositions and malpresentations of the fetal head. Obstetrics, Gynaecology & Reproductive Medicine 2012; 22(6): 155-61.
Sabaratnam Arulkumaran and Vikram Talaulikar. Fetal monitoring during labour, Chapter 27 in Oxford Textbook of Obstetrics and Gynaecology, Edited by Sabaratnam Arulkumaran, William Ledger, Lynette Denny, and Stergios Doumouchtsis. Pages 339-51. Oxford University Press. Published: 23 January 2020.
Mushi Matjila and Vikram Talaulikar. Miscarriage and recurrent miscarriage, Chapter 38 in Oxford Textbook of Obstetrics and Gynaecology, Edited by Sabaratnam Arulkumaran, William Ledger, Lynette Denny, and Stergios Doumouchtsis. Pages 477-88. Oxford University Press. Published: 23 January 2020.
Vikram Sinai Talaulikar, Sabaratnam Arulkumaran. Chapter 21 Birth Asphyxia in Arias’ Practical Guide to High-Risk Pregnancy and Delivery. A South Asian Perspective. Editors: Fernando Arias, Amarnath Bhide, Arulkumaran S, Kaizad Damania, Shirish Daftary. 4th Edition. Pages 359-72. Elsevier India, 2020.
Isaac Manyonda and Vikram Sinai Talaulikar. MRCOG Part 3: 50 Clinical Tasks. Publisher: Jaypee UK; 1 edition (22 Aug. 2019).
Talaulikar V, Arulkumaran S. Clinical Governance in Obstetrics and Gynaecology, chapter 5 in Professional Development Skills for Obstetricians and Gynaecologists edited by Tahir Mahmood, Sambit Mukhopadhyay, 1st edition, pages 52 -61, Cambridge University Press, UK 2018.
Talaulikar V, Arulkumaran S. CTG Interpretation. Chapter 25 in Medicolegal Issues in Obstetrics and Gynaecology edited by Swati Jha and Emma Ferriman, 1st edition, pages 133-8, Springer International Publishing AG, UK 2018.
Sinai Talaulikar V. Chapter 23 – Medicolegal Considerations of CTG in Handbook of cardiotocography edited by Roza Olyai; pages165-76, CBS Publishers & Distributors, India 2018.
Excellence in women’s healthcare
Disclaimer: the information on this site (“content”) is for general, informational and educational purposes only. The content is not intended to be used as a substitute for consulting with a physician for any specific diagnosis or treatment of any and all medical conditions. The information accessed through this site is provided “as is” and without warranty, either express or implied, including but not limited to implied warranties of merchantability or fitness for a particular purpose. The LUNA clinic makes no warranty as to the reliability, accuracy, timeliness, usefulness, or completeness of the information. The LUNA clinic and information providers cannot and do not warrant against human and machine errors, omissions, delays, interruptions, or losses, including loss of data. The LUNA clinic and information providers cannot and do not guarantee or warrant that files available for downloading from this site will be free of infection or viruses, worms, trojan horses or other code that manifest contamination or destructive properties. The LUNA clinic will in no event be liable for any damages whatsoever for consequential or incidental damages, either direct or indirectly including but not limited to loss of business profits, income, or use of data. Some states do not allow exclusion or limitation of incidental or consequential damages; therefore, the limitations set forth in this agreement may not apply to you. Pricing disclaimer – we do our utmost to ensure the prices on our company’s website are correct and keep our prices constant. Prices are subject to change without notice.